Novel blood test predicts kidney disease A blood test for detecting risk of developing diabetic kidney disease is now available in Australia, but a GP expert raises some concerns.
GLP-1 receptor agonists linked to kidney failure prevention: Study It found the diabetes and weight-loss drugs can reduce deterioration regardless of diabetes status, but supply remains an issue.
Could stricter salt ‘laws’ save lives? Researchers say manufacturers should be made to reduce sodium levels in packaged food, saying it will bring ‘enormous reductions’ in CVD.
In Practice: My Health Record education kit The RACGP’s updated self-directed learning activity is designed to help GPs better understand MHR and their own legal obligations.
Understanding the Intricacies of LFTs in Clinical Practice Dr Chanika Ariyawansa, who holds significant roles in the Australian Association of Clinical Biochemistry, delves into the nuances of liver function tests, exploring patterns and the implications of abnormal results.
Study links Ozempic to kidney failure prevention It found semaglutide reduced risk of major kidney events by 24% for type 2 diabetes patients, but GPs have urged caution.
Drug expanded on PBS for CKD treatment GPs can now prescribe empagliflozin for eligible patients with chronic kidney disease, but should be aware of specific eligibility criteria.
In Practice: Long COVID support for GPs The RACGP is hosting a CPD-approved session to keep GPs up to date with effective diagnosis and management for often complex long COVID conditions.
Research provides hope for type 1 diabetes ‘cure’ Further trials are needed, but the use of rare cancer drugs to assist in restoring insulin production is showing promise.
Future asthma risk flagged for babies with food allergy Even if the allergy is outgrown, poorer lung function outcomes are more likely by six years of age, a world-first study finds.